JPS6243490B2 - - Google Patents
Info
- Publication number
- JPS6243490B2 JPS6243490B2 JP11295579A JP11295579A JPS6243490B2 JP S6243490 B2 JPS6243490 B2 JP S6243490B2 JP 11295579 A JP11295579 A JP 11295579A JP 11295579 A JP11295579 A JP 11295579A JP S6243490 B2 JPS6243490 B2 JP S6243490B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- absorbance
- reagent
- enzyme
- nadh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000006243 chemical reaction Methods 0.000 claims description 54
- 238000002835 absorbance Methods 0.000 claims description 44
- 239000003153 chemical reaction reagent Substances 0.000 claims description 38
- 108090000790 Enzymes Proteins 0.000 claims description 26
- 102000004190 Enzymes Human genes 0.000 claims description 26
- 230000000694 effects Effects 0.000 claims description 25
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 238000006911 enzymatic reaction Methods 0.000 claims description 10
- 239000007844 bleaching agent Substances 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- 230000031700 light absorption Effects 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 31
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 31
- 239000000243 solution Substances 0.000 description 15
- 210000002966 serum Anatomy 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 230000002159 abnormal effect Effects 0.000 description 8
- 238000007792 addition Methods 0.000 description 8
- 230000000977 initiatory effect Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000005375 photometry Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical class NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000003028 enzyme activity measurement method Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 2
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- YBGBJYVHJTVUSL-UHFFFAOYSA-L disodium;2-oxopentanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CCC(=O)C([O-])=O YBGBJYVHJTVUSL-UHFFFAOYSA-L 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- PUWBXDQHRRUKNY-CKOVTTQDSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal phosphoric acid Chemical compound OP(O)(O)=O.OP(O)(O)=O.OP(O)(O)=O.OP(O)(O)=O.OP(O)(O)=O.OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O PUWBXDQHRRUKNY-CKOVTTQDSA-N 0.000 description 1
- 108010050201 2-hydroxybutyrate dehydrogenase Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 108010073976 UDP-GlcNAc-undecaprenyl phosphate N-acetylglucosaminyl 1-phosphate transferase Proteins 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000001268 chyle Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010799 enzyme reaction rate Methods 0.000 description 1
- 108010014487 geranylpyrophosphate olivetolate geranyltransferase Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 108010067653 lactate dehydratase Proteins 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
- G01N21/272—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration for following a reaction, e.g. for determining photometrically a reaction rate (photometric cinetic analysis)
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Mathematical Physics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11295579A JPS5637541A (en) | 1979-09-05 | 1979-09-05 | Analyzing apparatus of enzyme activity value |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11295579A JPS5637541A (en) | 1979-09-05 | 1979-09-05 | Analyzing apparatus of enzyme activity value |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5637541A JPS5637541A (en) | 1981-04-11 |
| JPS6243490B2 true JPS6243490B2 (ko) | 1987-09-14 |
Family
ID=14599706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11295579A Granted JPS5637541A (en) | 1979-09-05 | 1979-09-05 | Analyzing apparatus of enzyme activity value |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5637541A (ko) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63165796U (ko) * | 1987-03-30 | 1988-10-28 | ||
| US11344811B2 (en) | 2019-09-24 | 2022-05-31 | Square Enix Co., Ltd. | Computer-readable recording medium, computer apparatus, and method of progressing game |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5759150A (en) * | 1980-09-26 | 1982-04-09 | Olympus Optical Co Ltd | Method for biochemical analysis |
-
1979
- 1979-09-05 JP JP11295579A patent/JPS5637541A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63165796U (ko) * | 1987-03-30 | 1988-10-28 | ||
| US11344811B2 (en) | 2019-09-24 | 2022-05-31 | Square Enix Co., Ltd. | Computer-readable recording medium, computer apparatus, and method of progressing game |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5637541A (en) | 1981-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4612289A (en) | Method for analyzing liquid sample | |
| Curme et al. | Multilayer film elements for clinical analysis: general concepts. | |
| Tipton | Principles of enzyme assay and kinetic studies | |
| US5590052A (en) | Error checking in blood analyzer | |
| US5607565A (en) | Apparatus for measuring analytes in a fluid sample | |
| Cooper | Methods for determining the amount of glucose in blood | |
| EP0041366A1 (en) | Method for operating an apparatus for analysing samples optically | |
| US4599316A (en) | Photometric method for the determination of inorganic phosphate in liquid samples | |
| EP0268025B1 (en) | Method for analyzing a haemolysed blood sample | |
| Driscoll et al. | Discrete automated chemistry system with tableted reagents. | |
| Blanc et al. | Evaluation of a newly available biochemical analyzer: the Olympus AU 600 | |
| JPS6243490B2 (ko) | ||
| CN111455020A (zh) | 一种1,5-脱水山梨醇检测试剂盒及检测方法 | |
| US5025389A (en) | Method of analyzing reaction rate in chemical analysis | |
| Sonntag | Dry chemistry: analysis with carrier-bound reagents | |
| Coudène et al. | Evaluation of the ABX Pentra 400: a newly available clinical chemistry analyser | |
| Diamandis et al. | Kinetic potentiometric determination of creatinine in serum with a picrate ion-selective membrane electrode. | |
| JPS6118982B2 (ko) | ||
| Šperlingová et al. | Preparation of a reference material “Creatinine in Human Urine” | |
| JPH0257863B2 (ko) | ||
| Liedtke et al. | Centrifugal analysis with automated sequential reagent addition: measurement of serum calcium. | |
| Cynober et al. | Laboratory evaluation of the Koné" Progress" discrete analyzer. | |
| JPS6073465A (ja) | 自動分析装置 | |
| Lentjes et al. | Evaluation of the Hitachi 704 automatic analyzer. | |
| JPS6060558A (ja) | 複数測定分析法 |